|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine, University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA
2 Fred Hutchinson Cancer Research Center, Seattle, WA, USA
3 Veterans Administration Puget Sound Health Care System, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA
* To whom correspondence should be addressed. E-mail: dzager{at}fhcrc.org.
Background: Endotoxemia induces a hemodynamic form of acute renal failure (ARF) [renal vasoconstriction ± reduced glomerular ultrafilitration coefficient, Kf; minimal / no histologic damage]. This study tested whether levosimendan (LS), a KATP channel opener with cardiac ionotropic and possible anti-inflammatory properties, might have utility in combating this form of ARF. Methods: CD-1 mice were injected with lipopolysaccharide (LPS) ± LS. LS effects on LPS- induced systemic inflammation (plasma TNF-
/ MCP-1; cardio-renal mRNAs), plasma nitric oxide (NO) levels, and azotemia were assessed. Because KATP channel opening has been reported to mediate hypoxic tubular injury, possible adverse LS effects on ischemic ARF, and on ATP depletion- injury, were sought (in HK-2 cells and isolated mouse proximal tubules). The impacts of diazoxide (another KATP channel agonist) and glibenclamide (a channel antagonist) on hypoxic tubular injury were also assessed. Finally, the ability of LS to alter rat mesangial cell (MC) contraction in response to angiotensin II (AII; elevated in sepsis) was tested. Results: LS conferred almost complete protection against LPS-induced ARF. This occurred without any apparent reduction in the LPS- induced inflammatory response. Neither LS nor diazoxide altered ATP depletion- mediated tubule injury (in vivo or in vitro). Conversely, glibenclamide induced a marked and direct cytotoxic effect. LS completely blocked AII- induced MC contraction, an action likely to increase Kf. Conclusions: 1) LS can confer marked protection against LPS- induced ARF; 2) This likely stems from its vasoactive properties, rather than from reductions in LPS induced inflammation; and 3) KATP channel agonists (but not antagonists) appear to be devoid of toxic proximal tubular cell effects. This suggests that LS, and other KATP channel agonists, have a margin of safety if employed in situations (e.g., sepsis syndrome, heart failure) in which severe renal vasoconstriction might lead to ischemic ARF
This article has been cited by other articles:
![]() |
D. Cunha-Goncalves, V. Perez-de-Sa, A. Larsson, J. Thorne, and S. Blomquist Inotropic Support During Experimental Endotoxemic Shock: Part II. A Comparison of Levosimendan with Dobutamine Anesth. Analg., November 1, 2009; 109(5): 1576 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakamura, Y. Komagiri, T. Kojo, and M. Kubokawa Delayed and acute effects of interferon-{gamma} on activity of an inwardly rectifying K+ channel in cultured human proximal tubule cells Am J Physiol Renal Physiol, January 1, 2009; 296(1): F46 - F53. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Nieminen, J. G.F. Cleland, J. Eha, Y. Belenkov, M. Kivikko, P. Poder, and T. Sarapohja Oral levosimendan in patients with severe chronic heart failure--The PERSIST study Eur J Heart Fail, December 1, 2008; 10(12): 1246 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Sun, X. Zhang, K. Ito, Y. Li, R. A. Montgomery, S. Tachibana, and G. M. Williams Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide Am J Physiol Renal Physiol, March 1, 2008; 294(3): F491 - F498. [Abstract] [Full Text] [PDF] |
||||
|
|
A. G. Zenovich and D. A. Taylor CELL THERAPY IN KIDNEY DISEASE: CAUTIOUS OPTIMISM... BUT OPTIMISM NONETHELESS Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S94 - S103. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wu, M. M. Tiwari, K. J. Messer, J. H. Holthoff, N. Gokden, R. W. Brock, and P. R. Mayeux Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice Am J Physiol Renal Physiol, January 1, 2007; 292(1): F261 - F268. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |